Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Intraocular Lymphoma × Lens Implantation, Intraocular × Lymphoid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Intraocular Lymphoma 1

Interventions

Rituximab 15 Peripheral Blood Stem Cell Transplantation 13 Cyclophosphamide 12 fludarabine phosphate 11 Whole-Body Irradiation 9 Cyclosporine 9 Mycophenolic Acid 8 Filgrastim 8 Methotrexate 7 Lenalidomide 7 Etoposide 7 Tacrolimus 5 Radiotherapy 5 Dexamethasone 5 Cytarabine 5 Vorinostat 4 Therapeutics 4 Psychiatric Rehabilitation 4 Melphalan 4 Carboplatin 4 Antilymphocyte Serum 4 Thiotepa 3 Irinotecan 3 Granulocyte Colony-Stimulating Factor 3 Flow Cytometry 3 Dasatinib 3 Busulfan 3 Bortezomib 3 tanespimycin 2 pegfilgrastim 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03157375 2017-05-17

Rot P261

Medical University of Vienna

Phase NA Completed

Intraocular Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡